Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
66,373,956
-
Share change
-
-851,706
-
Total reported value
-
$439,416,816
-
Put/Call ratio
-
119%
-
Price per share
-
$6.62
-
Number of holders
-
116
-
Value change
-
-$4,341,017
-
Number of buys
-
38
-
Number of sells
-
70
Institutional Holders of KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) as of Q2 2016
As of 30 Jun 2016,
KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) was held by
116 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,373,956 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, ABRAMS CAPITAL MANAGEMENT, L.P., FMR LLC, STATE STREET CORP, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, NORGES BANK, AMERIPRISE FINANCIAL INC, and MILLENNIUM MANAGEMENT LLC.
This page lists
116
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.